Journal
FRONTIERS IN ONCOLOGY
Volume 6, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2016.00215
Keywords
MR-linac; MRI; linear accelerator; radiotherapy; consortium; innovation
Categories
Funding
- Medical Research Council [MC_EX_MR/M009068/1, MR/M009068/1] Funding Source: Medline
- Cancer Research UK [21993] Funding Source: researchfish
- Medical Research Council [MR/M009068/1, MC_EX_MR/M009068/1] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0515-10101] Funding Source: researchfish
- MRC [MR/M009068/1, MC_EX_MR/M009068/1] Funding Source: UKRI
Ask authors/readers for more resources
An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available